Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs

It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or d...

Descripción completa

Detalles Bibliográficos
Autores principales: Layton, Jodi L., Lewis, Brian, Ryan, Charles, Beer, Tomasz M., Sartor, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519754/
https://www.ncbi.nlm.nih.gov/pubmed/30568023
http://dx.doi.org/10.1634/theoncologist.2018-0565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519754/
https://www.ncbi.nlm.nih.gov/pubmed/30568023
http://dx.doi.org/10.1634/theoncologist.2018-0565

Ejemplares similares